knowledge -WSS

knowledge

author：Wikipedia 2025-10-02 22:56:50 - browse：18917

Illustration of a red human heart with an EKG line in the middle. -- health coverage from STAT — Adobe

Just weeks after Novo Nordisk announced that its obesity drug Wegovy cut the risk of heart complications in a major trial, the company now has results from a different study showing the treatment can also benefit people with a common type of heart failure.

The results, published Friday in the New England Journal of Medicine, found that among people with obesity and heart failure with preserved ejection fraction, or HFpEF, those taking Wegovy experienced greater improvements in symptoms and physical function compared with those on placebo. The improvements were greater than what’s been seen in trials of some other HFpEF treatments.

Novo previously shared topline results in investor calls, but the new study contains the full findings, which are also being presented at the European Society of Cardiology conference this week.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： Amazon on where the company's health care bets are headed next

WSS

Public funding for King Charles III and royals has been recalculated due to windfarm deal profits

Crinetics acromegaly drug succeeds in late

Vir antibody drug aimed at influenza A fails in clinical trial

Driven by the pandemic, applicants flood public health schools

Stanford president's case begs question: Who takes blame?

A rare thyroid diagnosis led to unexpected, all

knowledge

knowledge

entertainment

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

7 more heat

As demand for Covid shots wanes, Moderna seeks its next success

NIH nominee Bertagnolli will get October confirmation hearing

Sports medicine is finally prioritizing gender equality

The 10 drugs up first for Medicare price negotiation

Anesthesiologist group: stop taking Ozempic before surgery

Ethical issues complicate the benefits of medical crowdfunding

Psychedelics group wrestles with new pharma identity

Ethical issues complicate the benefits of medical crowdfunding

entertainment

Ethical issues complicate the benefits of medical crowdfunding

Affordable Connectivity Program vital to health care, experts say

EF3 tornado rips through North Carolina amid extreme weather nationwide

Humana sues Biden admin over Medicare Advantage audit rule

How generative AI is inspiring dreams of a health data revolution

Amazon on where the company's health care bets are headed next

focus

knowledge

Wikipedia

Wikipedia